Medivir
2.69 SEK
+12.58 %
Less than 1K followers
MVIR
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Medivir
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.9 | 1.0 | 3.5 | 0.6 | 1.5 | 0.9 | 5.5 | 8.5 |
| EBITDA | -35.1 | -26.2 | -124.6 | -12.6 | -22.5 | -12.9 | -12.0 | -60.1 |
| EBIT | -35.7 | -26.9 | -127.3 | -13.3 | -23.2 | -13.6 | -42.5 | -92.6 |
| EBIT-% | -3,966.7 % | -2,690.0 % | -3,637.1 % | -2,216.7 % | -1,546.7 % | -1,511.1 % | -772.7 % | -1,089.4 % |
| Profit before taxes | -34.6 | -26.7 | -123.3 | -13.3 | -23.3 | -14.6 | -43.2 | -94.4 |
| Net income | -34.6 | -26.7 | -123.3 | -13.3 | -23.3 | -14.6 | -43.2 | -94.4 |